Clinical Characteristics and Risk Factors for Bloodstream Infection Due to Carbapenem-Resistant Klebsiella pneumoniae in Patients with Hematologic Malignancies

References

• Gajdacs M, Albericio F. Antibiotic resistance: from the bench to patients. Antibiotics (Basel). 2019;8.
   Web of Science ®Google Scholar
• Gajdács M. The concept of an ideal antibiotic: implications for drug design. Molecules. 2019;24:892. doi:10.3390/molecules24050892
   PubMed Web of Science ®Google Scholar
• Hu F, Zhu D, Wang F, Wang M. Current status and trends of antibacterial resistance in China. Clin Infect Dis. 2018;67:S128–S34. doi:10.1093/cid/ciy65730423045
   PubMed Web of Science ®Google Scholar
• Hu F, Guo Y, Yang Y, et al. Resistance reported from China antimicrobial surveillance network (CHINET) in 2018. Eur J Clin Microbiol Infect Dis. 2019;38(12):2275–2281. doi:10.1007/s10096-019-03673-131478103
   PubMed Web of Science ®Google Scholar
• Fasciana T, Gentile B, Aquilina M, et al. Co-existence of virulence factors and antibiotic resistance in new Klebsiella pneumoniae clones emerging in south of Italy. BMC Infect Dis. 2019;19:10. doi:10.1186/s12879-019-4565-330611208
   PubMed Web of Science ®Google Scholar
• Satlin MJ, Jenkins SG, Walsh TJ. The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies. Clin Infect Dis. 2014;58:1274–1283. doi:10.1093/cid/ciu05224463280
   PubMed Web of Science ®Google Scholar
• Misch EA, Andes DR. Bacterial infections in the stem cell transplant recipient and hematologic malignancy patient. Infect Dis Clin North Am. 2019;33:399–+. doi:10.1016/j.idc.2019.02.011
   Web of Science ®Google Scholar
• Xu B, Huang SM, He LL, et al. Hematologic malignancies and carbapenem resistance: a multicentre retrospective study from Chinese people. Blood. 2017;130:1.28684444
   PubMed Web of Science ®Google Scholar
• States U Antibiotic resistance threats in the United States, 2013; 2013.
   Google Scholar
• Trecarichi EM, Tumbarello M, Di Blasi R, et al. Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: incidence and clinical impact of carbapenem resistance in a multicentre prospective survey. Blood. 2015;126(23):3. doi:10.1182/blood.V126.23.3757.3757
   Web of Science ®Google Scholar
• Girmenia C, Rossolini GM, Piciocchi A, et al. Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy. Bone Marrow Transplant. 2015;50:282–288. doi:10.1038/bmt.2014.23125310302
   PubMed Web of Science ®Google Scholar
• Tofas P, Skiada A, Angelopoulou M, et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections in neutropenic patients with haematological malignancies or aplastic anaemia: analysis of 50 cases. Int J Antimicrob Agents. 2016;47:335–339. doi:10.1016/j.ijantimicag.2016.01.01127005460
   PubMed Web of Science ®Google Scholar
• Trecarichi EM, Pagano L, Martino B, et al. Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey. Am J Hematol. 2016;91:1076–1081. doi:10.1002/ajh.2448927428072
   PubMed Web of Science ®Google Scholar
• Webb BJ, Healy R, Majers J, et al. Prediction of bloodstream infection due to vancomycin-resistant enterococcus in patients undergoing leukemia induction or hematopoietic stem-cell transplantation. Clin Infect Dis. 2017;64:1753–1759. doi:10.1093/cid/cix23228369204
   PubMed Web of Science ®Google Scholar
• Pagano L, Caira M, Trecarichi EM, et al. Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies. Emerg Infect Dis. 2014;20:1235–1236. doi:10.3201/eid2007.13009424960464
   PubMed Web of Science ®Google Scholar
• Satlin MJ, Calfee DP, Chen L, et al. Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies. Leuk Lymphoma. 2013;54:799–806. doi:10.3109/10428194.2012.72321022916826
   PubMed Web of Science ®Google Scholar
• Gajdacs M, Batori Z, Abrok M, Lazar A, Burian K. Characterization of resistance in gram-negative urinary isolates using existing and novel indicators of clinical relevance: a 10-year data analysis. Life (Basel). 2020;10:16.
   Web of Science ®Google Scholar
• Liu J, Wang H, Huang Z, et al. Risk factors and outcomes for carbapenem-resistant Klebsiella pneumoniae bacteremia in onco-hematological patients. J Infect Dev Ctries. 2019;13:357–364. doi:10.3855/jidc.1118932053504
   PubMed Web of Science ®Google Scholar
• Corcione S, Angilletta R, Raviolo S, et al. Epidemiology and risk factors for mortality in bloodstream infection by CP-Kp, ESBL-E, Candida and CDI: a single center retrospective study. Eur J Intern Med. 2018;48:44–49. doi:10.1016/j.ejim.2017.10.01529096992
   PubMed Web of Science ®Google Scholar
• Satlin MJ, Jenkins SG, Chen L, et al. Septic shock caused by Klebsiella pneumoniae carbapenemase-producing Enterobacter gergoviae in a neutropenic patient with leukemia. J Clin Microbiol. 2013;51:2794–2796.23761145
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Spanu T, Caira M, et al. Factors associated with mortality in bacteremic patients with hematologic malignancies. Diagn Microbiol Infect Dis. 2009;64:320–326. doi:10.1016/j.diagmicrobio.2009.02.00819345033
   PubMed Web of Science ®Google Scholar
• Tang YS, Cheng Q, Yang Q, et al. Prognostic factors and scoring model of hematological malignancies patients with bloodstream infections. Infection. 2018;46:513–521. doi:10.1007/s15010-018-1151-329767394
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Viale P, Viscoli C, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis. 2012;55:943–950. doi:10.1093/cid/cis58822752516
   PubMed Web of Science ®Google Scholar
• Daikos GL, Tsaousi S, Tzouvelekis LS, et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother. 2014;58:2322–2328. doi:10.1128/AAC.02166-1324514083
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Trecarichi EM, De Rosa FG, et al. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother. 2015;70:2133–2143. doi:10.1093/jac/dkv08625900159
   PubMed Web of Science ®Google Scholar
• Giannella M, Trecarichi EM, De Rosa FG, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study. Clin Microbiol Infect. 2014;20:1357–1362. doi:10.1111/1469-0691.1274724980276
   PubMed Web of Science ®Google Scholar
• Amit S, Mishali H, Kotlovsky T, Schwaber MJ, Carmeli Y. Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors. Clin Microbiol Infect. 2015;21(1):30–34. doi:10.1016/j.cmi.2014.08.00125636924
   PubMed Web of Science ®Google Scholar
• Bellot P, Frances R, Such J. Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications. Liver Int. 2013;33:31–39. doi:10.1111/liv.1202123121656
   PubMed Web of Science ®Google Scholar
• Wang F, Li Q, Wang C, Tang C, Li J. Dynamic alteration of the colonic microbiota in intestinal ischemia-reperfusion injury. PLoS One. 2012;7:e42027. doi:10.1371/journal.pone.004202722848694
   PubMed Web of Science ®Google Scholar
• Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections - a risk factor for hospital mortality among critically ill patients. Chest. 1999;115(2):462–474. doi:10.1378/chest.115.2.46210027448
   PubMed Web of Science ®Google Scholar
• Cattaneo C, Di Blasi R, Skert C, et al. Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria. Ann Hematol. 2018;97(9):1717–1726. doi:10.1007/s00277-018-3341-629705860
   PubMed Web of Science ®Google Scholar
• Borer A, Saidel-Odes L, Eskira S, et al. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae. Am J Infect Control. 2012;40:421–425. doi:10.1016/j.ajic.2011.05.02221906844
   PubMed Web of Science ®Google Scholar
• Gasink LB, Edelstein PH, Lautenbach E, Synnestvedt M, Fishman NO. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol. 2009;30:1180–1185. doi:10.1086/64845119860564
   PubMed Web of Science ®Google Scholar
• Orsi GB, Garcia-Fernandez A, Giordano A, et al. Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients. J Hosp Infect. 2011;78:54–58. doi:10.1016/j.jhin.2011.01.01421450365
   PubMed Web of Science ®Google Scholar
• Gajdacs M, Abrok M, Lazar A, Burian K. Comparative epidemiology and resistance trends of common urinary pathogens in a tertiary-care hospital: a 10-year surveillance study. Medicina (Kaunas). 2019;55:356.
   Web of Science ®Google Scholar